用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Metal Compounds in Cancer Therapy; Simon P. Fricker Book 1994 Springer Science+Business Media Dordrecht 1994 cancer.cancer therapy.clinica

[复制链接]
楼主: ED431
发表于 2025-3-27 00:23:06 | 显示全部楼层
发表于 2025-3-27 04:00:54 | 显示全部楼层
,Organometallic titanium, vanadium, niobium, molybdenum and rhenium complexes — early transition metham in 1954 and is today an important organometallic compound used as ‘Ziegler-Natta-catalyst’, e.g. for the polymerization of alkenes and organosilicon compounds, and as a precursor of reagents in organic synthesis (Haiduc and Zuckerman, 1985).
发表于 2025-3-27 09:00:19 | 显示全部楼层
Book 1994r international research effort investigating the potential of metal compounds in cancer therapy. Cisplatin now occupies an important place in the armamentarium of the oncologist due to its effectiveness in the treatment of testicular cancer. A second generation analogue, carbo­ platin, offers reduc
发表于 2025-3-27 11:31:04 | 显示全部楼层
发表于 2025-3-27 16:16:26 | 显示全部楼层
Gallium compounds in cancer therapy,isotopes, .Ga and .Ga, possess nuclear properties, and .Ga has been widely used in nuclear medicine imaging (Edwards and Hayes, 1969). The . antitumour effects of the stable .Ga. ion were described for the first time by Hart and Adamson (1971).
发表于 2025-3-27 20:51:54 | 显示全部楼层
发表于 2025-3-28 00:02:53 | 显示全部楼层
Gold, sun (Higby, 1982). Modern medicine dismisses such uses for lack of plausible mechanisms. Yet, one can still obtain a modern descendant of such treatments. ‘Goldwasser’ is a liqueur containing particles of elemental gold foil (about 10 cents’ worth of gold in a litre) and reputed to have medicinal properties.
发表于 2025-3-28 05:08:57 | 显示全部楼层
发表于 2025-3-28 06:56:39 | 显示全部楼层
发表于 2025-3-28 12:29:37 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-29 18:11
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表